Biosimilars have emerged as a significant advancement in the field of rheumatology, offering a new paradigm in the treatment ...

Revenues of Indian pharmaceutical companies are projected to grow by 9-11% in the current financial year, a moderation from ...

This projected revenue, as per the rating agency, will be driven by 9-11 per cent growth from the US market, 7-9 per cent each from the European and domestic markets, and 11-13 per cent from the ...

Quality issues were found in several generic drugs by regulatory agencies in Tamil Nadu and Maharashtra. Alerts have been ...